A CVID patient with NF-kB2 loss-of-function variant who developed severe COVID-19 and a patient with TBK1 and TNFRSF13B mutations and an auto-inflammatory disease with lethal COVID-19 were reported (9, 10). This evidence concerns the gene NFKB2 and COVID-19.